Aripiprazole is a new chemical entity with a unique pharmacological profile. It has strong affinities for certain dopamine receptors, and intermediate affinity for serotonin, adrenergic and histamine receptors. Partial agonism of the D2 dopamine and 5HT1A serotonin receptors, and antagonism of the 5HT...
european pharmacopoeia 8.1capecitabine 04/2014:2762 capecitabine capecitabinum c 15 h 22 fn 3 o 6 m r 359.3 [154361-50-9] definition pentyl [1-(5-deoxy-β- d-ribofuranosyl)-5-fluoro-2-oxo-1,2- dihydropyrimidin-4-yl]carbamate. content: 98.0 per cent to 102.0 per cent (anhydrous ...
(13.3) 5 (3.5) 4 (2.8) 5 (3.5) 1 (0.7) 97 (9.0) 42 (3.9) 37 (3.4) 16 (1.5) 4 (0.4) Abbreviation: AE, adverse event; AOM 400, aripiprazole once-monthly 400 mg; EPS, extrapyramidal symptoms; TEAE, treatment-emergent AE (AEs that started after initiating study drug treatment, ...
Methods. Two case studies of delirium that were treated with 30 mg and 15 mg aripiprazole were described. The improvement of delirium was monitored using the Mini-Mental Status Exam (MMSE) and Delirium Rating Scale (DRS). Results. In both cases, the patients' confusion, disorientation, and ...